AC

Alison Coutts

Ms Alison Coutts has extnsive experience across a number of industry sectors and disciplines. This includes international engineering project management, strategy consulting, executive search, investment banking and technology commercialisation. Prior to her role at Memphasys, Ms Coutts co-founded various businesses including a corporate finance advisory business, a clinical development stage drug development company focussing on chronic obstructive pulmonary disease and a medical device company that is developing innovative, lightweight mobile X-Ray machines for medical use. She is member of Risk Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/06/2377,847,3757,137,9441,593,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
30/12/22
Buy
392,500$0.014$5,416On-market trade
30/12/22
Buy
2,223$0.013$30On-market trade
28/09/22
Issued
1,050,150$0.020$21,003Rights issue
28/09/22
Issued
2,917,530$0.020$58,350Rights issue
28/09/22
Buy
1,000,000$0.020$20,000Off-market trade